Leah L Zullig1, William R Carpenter, Dawn Provenzale, Morris Weinberger, Bryce B Reeve, George L Jackson. 1. Leah L. Zullig, Dawn Provenzale, Morris Weinberger, and George L. Jackson, Center of Excellence for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center; Dawn Provenzale and George L. Jackson, Duke University, Durham; and Leah L. Zullig, William R. Carpenter, Morris Weinberger, and Bryce B. Reeve, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Abstract
PURPOSE: Racial disparities in cancer treatment and outcomes are a national problem. The nationwide Veterans Affairs (VA) health system seeks to provide equal access to quality care. However, the relationship between race and care quality for veterans with colorectal cancer (CRC) treated within the VA is poorly understood. We examined the association between race and receipt of National Comprehensive Cancer Network guideline-concordant CRC care. PATIENTS AND METHODS: This was an observational, retrospective medical record abstraction of patients with CRC treated in the VA. Two thousand twenty-two patients (white, n = 1,712; African American, n = 310) diagnosed with incident CRC between October 1, 2003, and March 31, 2006, from 128 VA medical centers, were included. We used multivariable logistic regression to examine associations between race and receipt of guideline-concordant care (computed tomography scan, preoperative carcinoembryonic antigen, clear surgical margins, medical oncology referral for stages II and III, fluorouracil-based adjuvant chemotherapy for stage III, and surveillance colonoscopy for stages I to III). Explanatory variables included demographic and disease characteristics. RESULTS: There were no significant racial differences for receipt of guideline-concordant CRC care. Older age at diagnosis was associated with reduced odds of medical oncology referral and surveillance colonoscopy. Presence of cardiovascular comorbid conditions was associated with reduced odds of medical oncology referral (odds ratio, 0.65; 95% CI, 0.50 to 0.89). CONCLUSION: In these data, we observed no evidence of racial disparities in CRC care quality. Future studies could examine causal pathways for the VA's equal, quality care and ways to translate the VA's success into other hospital systems.
PURPOSE: Racial disparities in cancer treatment and outcomes are a national problem. The nationwide Veterans Affairs (VA) health system seeks to provide equal access to quality care. However, the relationship between race and care quality for veterans with colorectal cancer (CRC) treated within the VA is poorly understood. We examined the association between race and receipt of National Comprehensive Cancer Network guideline-concordant CRC care. PATIENTS AND METHODS: This was an observational, retrospective medical record abstraction of patients with CRC treated in the VA. Two thousand twenty-two patients (white, n = 1,712; African American, n = 310) diagnosed with incident CRC between October 1, 2003, and March 31, 2006, from 128 VA medical centers, were included. We used multivariable logistic regression to examine associations between race and receipt of guideline-concordant care (computed tomography scan, preoperative carcinoembryonic antigen, clear surgical margins, medical oncology referral for stages II and III, fluorouracil-based adjuvant chemotherapy for stage III, and surveillance colonoscopy for stages I to III). Explanatory variables included demographic and disease characteristics. RESULTS: There were no significant racial differences for receipt of guideline-concordant CRC care. Older age at diagnosis was associated with reduced odds of medical oncology referral and surveillance colonoscopy. Presence of cardiovascular comorbid conditions was associated with reduced odds of medical oncology referral (odds ratio, 0.65; 95% CI, 0.50 to 0.89). CONCLUSION: In these data, we observed no evidence of racial disparities in CRC care quality. Future studies could examine causal pathways for the VA's equal, quality care and ways to translate the VA's success into other hospital systems.
Authors: Mary Beth Landrum; Nancy L Keating; Elizabeth B Lamont; Samuel R Bozeman; Barbara J McNeil Journal: Cancer Date: 2011-11-09 Impact factor: 6.860
Authors: Jaime Benarroch-Gampel; Kristin M Sheffield; Yu-Li Lin; Yong-Fang Kuo; James S Goodwin; Taylor S Riall Journal: Health Serv Res Date: 2011-12-08 Impact factor: 3.402
Authors: Leah L Zullig; George L Jackson; Raye Anne Dorn; Dawn T Provenzale; Rebecca McNeil; Catherine M Thomas; Michael J Kelley Journal: Mil Med Date: 2012-06 Impact factor: 1.437
Authors: Greg Yothers; Daniel J Sargent; Norman Wolmark; Richard M Goldberg; Michael J O'Connell; Jacqueline K Benedetti; Leonard B Saltz; James J Dignam; A William Blackstock Journal: J Natl Cancer Inst Date: 2011-10-12 Impact factor: 13.506
Authors: Carrie N Klabunde; Julie M Legler; Joan L Warren; Laura-Mae Baldwin; Deborah Schrag Journal: Ann Epidemiol Date: 2007-05-25 Impact factor: 3.797
Authors: Kelsey Lau-Min; Preeti Prakash; Eunji Jo; Aaron P Thrift; Susan Hilsenbeck; Benjamin L Musher Journal: Clin Colorectal Cancer Date: 2020-01-02 Impact factor: 4.481
Authors: George L Jackson; Leah L Zullig; Sean M Phelan; Dawn Provenzale; Joan M Griffin; Steven B Clauser; David A Haggstrom; Rahul M Jindal; Michelle van Ryn Journal: Cancer Date: 2015-03-17 Impact factor: 6.860
Authors: Leah L Zullig; Karen M Goldstein; Kellie J Sims; Christina D Williams; Michael Chang; Dawn Provenzale; Michael J Kelley Journal: J Womens Health (Larchmt) Date: 2018-06-19 Impact factor: 2.681
Authors: Lisa P Spees; Stephanie B Wheeler; Mahesh Varia; Morris Weinberger; Christopher D Baggett; Xi Zhou; Victoria M Petermann; Wendy R Brewster Journal: Gynecol Oncol Date: 2018-11-12 Impact factor: 5.482
Authors: Cleo A Samuel; Mary Beth Landrum; Barbara J McNeil; Samuel R Bozeman; Christina D Williams; Nancy L Keating Journal: Am J Public Health Date: 2014-09 Impact factor: 9.308
Authors: Arica White; Sun Hee Rim; Djenaba A Joseph; Christopher J Johnson; Michel P Coleman; Claudia Allemani Journal: Cancer Date: 2018-04-30 Impact factor: 6.860
Authors: Daniel J Becker; Kyung M Lee; Steve Y Lee; Kristine E Lynch; Danil V Makarov; Scott E Sherman; Christy D Morrissey; Michael J Kelley; Julie A Lynch Journal: JCO Precis Oncol Date: 2021-04-13